<DOC>
	<DOC>NCT02431013</DOC>
	<brief_summary>This is a randomized, open-label, single &amp; multiple-dose, parallel study to investigate the effect of cilostazol on the disposition of simvastatin &amp; pravastatin in healthy male volunteers</brief_summary>
	<brief_title>Cilostazol-Simvastatin Drug Interaction Study</brief_title>
	<detailed_description>Eligibility for participation of this study will be determined from demographic information, medical history, physical examination, electrocardiogram (ECG) and clinical laboratory tests within 4 weeks before study drug administration. Subjects suitable for this study will be admitted to the Clinical Trial Center of Ajou University Medical Center on the day before dosing (Day -1). On Day 1, Subjects will be dosed simvastatin 40 mg or pravastatin 20 mg. Pharmacokinetic samplings and blood pressure/pulse rate measurement will be done upto 24 hours after dosing. From Day 2 ~ 7, Subjects will be dosed cilostazol 100 mg twice a day. On Day 8, Subjects will be dosed simvastatin 40 mg or pravastatin 20 mg with cilostazol 100 mg twice a day. Pharmacokinetic samplings and blood pressure/pulse rate measurement will be done upto 24 hours after dosing.</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Healthy male subjects aged 20 45 years With in 20% of ideal body weight, {Ideal body weight=[height(cm)100]*0.9} Agreement with written informed consent Clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal disease or mental disorder (Past history or present) Inadequate result of laboratory test (especially, AST/ALT &gt; 1.25 x UNL, Total bilirubin &gt; 1.5 x UNL) Positive reaction in the HBs Ag, antiHCV Ab, antiHIV Ab, VDRL test Taking OTC(Over the counter)medicine including oriental medicine within 7 days Clinically significant allergic disease (Except for mild allergic rhinitis and dermatitis seems to be not need for medication) Subject with known for hypersensitivity reaction to Cilostazol, Simvastatin or Pravastatin Previous whole blood donation within 60 days or component blood donation within 30 days Previous participation of other trial within 90 days Continued taking caffeine (caffeine &gt; 5 cup/day), drinking (alcohol &gt; 30 g/day) and severe heavy smoker (cigarette &gt; 1/2 pack per day) An impossible one who participates in clinical trial by investigator's decision including for reason of laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Drug-drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>